Coronaviruses post-SARS: Update on replication and pathogenesis

Nature Reviews Microbiology

Volumn 7, Issue 6, 2009, Pages 439-450

  Perlman, Stanley ^a   Netland, Jason ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON COLD; CORONAVIRUS; DISEASE MODEL; DOMESTIC ANIMAL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTESTINE INFECTION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS CELL INTERACTION; VIRUS IDENTIFICATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; MODELS, BIOLOGICAL; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS;

EID: 67349158649     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2147     Document Type: Review

References (142)

1. Peiris, J. S., Guan, Y. & Yuen, K. Y. Severe acute respiratory syndrome. Nature Med. 10, S88-S97 (2004).
2. Barcena, M. et al. Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc. Natl Acad. Sci. USA 106, 582-587 (2009).
3. Neuman, B. W. et al. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J. Virol. 80, 7918-7928 (2006).
4. Masters, P. S. The molecular biology of coronaviruses. Adv. Virus Res. 66, 193-292 (2006).
5. Lissenberg, A. et al. Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. J. Virol. 79, 15054-15063 (2005).
6. -/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J. Virol. 78, 10156-10165 (2004).
7. Weiss, S. R. & Navas-Martin, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69, 635-664 (2005).
8. Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454 (2003).
9. Li, W. et al. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology 367, 367-374 (2007).
10. Hofmann, H. et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl Acad. Sci. USA 102, 7988-7993 (2005).
11. Kuba, K. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Med. 11 875-879 (2005).
12. Imai, Y. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112-116 (2005).
13. Ning, Q. et al. Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4α. J. Biol. Chem. 278, 15541-15549 (2003).
14. Zhao, X., Nicholls, J. M. & Chen, Y. G. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling. J. Biol. Chem. 283, 3272-3280 (2008).
15. DeDiego, M. L. et al. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J. Virol. 81, 1701-1713 (2007).
16. Kuo, L. & Masters, P. S. The small envelope protein E is not essential for murine coronavirus replication. J. Virol. 77, 4597-4608 (2003).
17. Ortego, J., Ceriani, J. E., Patino, C., Plana, J. & Enjuanes, L. Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway. Virology 368, 296-308 (2007).
18. Madan, V., Garcia Mde, J., Sanz, M. A. & Carrasco, L. Viroporin activity of murine hepatitis virus E protein. FEBS Lett. 579, 3607-3612 (2005).
19. Wilson, L., McKinlay, C., Gage, P. & Ewart, G. SARS coronavirus E protein forms cation-selective ion channels. Virology 330, 322-331 (2004).
20. Yount, B. et al. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J. Virol. 79, 14909-14922 (2005).
21. Ontiveros, E., Kuo, L., Masters, P. S. & Perlman, S. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology 290, 230-238 (2001).
22. de Haan, C. A., Masters, P. S., Shen, X., Weiss, S. & Rottier, P. J. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 296, 177-189 (2002).
23. Li, W. et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 310, 676-679 (2005).
24. Fischer, F., Peng, D., Hingley, S. T., Weiss, S. R. & Masters, P. S. The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J. Virol. 71, 996-1003 (1997).
25. Huang, C., Peters, C. J. & Makino, S. Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J. Virol. 81, 5423-5426 (2007).
26. Ito, N. et al. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J. Virol. 79, 3182-3186 (2005).
27. Schaecher, S. R., Mackenzie, J. M. & Pekosz, A. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J. Virol. 81, 718-731 (2007).
28. Neuman, B. W. et al. Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J. Virol. 82 5279-5294 (2008).
29. Sawicki, S. G., Sawicki, D. L. & Siddell, S. G. A contemporary view of coronavirus transcription. J. Virol. 81, 20-29 (2007).
30. Anand, K., Ziebuhr, J., Wadbwani, P., Mesters, J. R. & Hilgenfeld, R. Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science 300, 1763-1767 (2003).
31. Zhai, Y. et al. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nspB hexadecamer. Nature Struct. Mol. Biol. 12, 980-986 (2005).
32. Chatterjee, A. et al. Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold. J. Virol. 83, 1823-1836 (2009).
33. Joseph, J. S. et al. Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronaviruis reveals a novel fold with two zinc-binding motifs. J. Virol. 60, 7894-7901 (2006).
34. Joseph, J. S. et al. Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp 15 suggests a role for hexamerization as an allosteric switch. J. Virol. 81, 6700-6708 (2007).
35. Peti, W. et al. Structural genomics of the severe acute respiratory syndrome coronavirus: Nuclear magnetic resonance structure of the protein nsP7. J. Virol. 79, 12905-12913 (2005).
36. Saikatendu, K. S. et al. Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose- 1″ - phosphate dephosphorylation by a conserved domain. of nsP3. Structure 13 1665-1675 (2005).
37. Almeida, M. S., Johnson, M. A., Herrmann, T,. Geralt, M. & Wuthrich, K. Novel β-barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus. J. Virol. 81, 3151-3161 (2007).
38. Serrano, P. et al. Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus. J. Virol. 81, 12049-12060 (2007).
39. Ricagno, S. et al. Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family. Proc. Natl Acad. Sci. USA 103, 11892-11897 (2006).
40. Su, D. et al. Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp 10. J. Virol. 80 7902-7908 (2006).
41. Snijder, E. J. et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331, 991-1004 (2003).
42. Imbert, I. et al. A second, non-canonical RNA- dependent RNA polymerase in SARS coronavirus. EMBO J. 25, 4933-4942 (2006).
43. Ratia, K. et al. Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme. Proc. Natl Acad. Sci. USA 103, 5717-5722 (2006).
44. Deming, D. J., Graham, R. L., Denison, M. R. & Baric, R. S. Processing of open reading frame 1a replicase proteins nsp7 to nsp 10 in murine hepatitis virus strain A59 replication. J. Virol. 81, 10280-10291 (2007).
45. Egloff, M. P. et al. The severe acute respiratory syndrome-coronavinus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc. Natl Acad. Sci. USA 101, 3792-3796 (2004).
46. Donaldson, E. F., Sims, A. C., Graham, R. L., Denison, M. R. & Baric, R. S. Murine hepatitis virus replicase protein nsp 10 is a critical regulator of viral RNA synthesis. J. Virol. 81, 6356-6368 (2007).
47. Eckerle, L. D., Lu, X., Sperry, S. M., Choi, L. & Denison, M. R. High fidelity of murine hepatitis virus replication is decreased in nsp 14 exoribonuclease mutants. J. Virol. 81, 12135-12144 (2007).
48. Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi: 10.1073/pnas.0808790106).
49. Ivanov, K. A. et al. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl Acad. Sci. USA 101, 12694-12699 (2004).
50. Decroly, E. et al. Coronavinus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2′O)-methyltransferase activity. J. Virol. 82, 8071-8084 (2008).
51. Snijder, E. J. et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 80, 5927-5940 (2006).
52. de Haan, C. A. & Rottier, P. J. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 64, 165-230 (2005).
53. Prentice, E., Jerome, W. G., Yoshimori, T., Mizushima, N. & Denison, M. R. Coronavirus replication complex formation utilizes components of cellular autophagy. J. Biol. Chem. 279, 10136-10141 (2004).
54. Zhao, Z. et al. Coronavirus replication does not require the autophagy gene ATC5. Autophagy 3, 581-585 (2007).
55. Bechill, J., Chen, Z., Brewer, J. W. & Baker, S. C. Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. J. Virol. 82, 4492-4501 (2008).
56. Knoops, K. et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 6, e226 (2008).
57. Snijder, E. J., van Tol, H., Roos, N. & Pedersen, K. W. Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex. J. Gen. Virol. 82, 985-994 (2001)
58. Clementz, M. A., Kanjanahaluethai, A., O'Brien, T. E. & Baker, S. C. Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles. Virology 375, 118-129 (2008).
59. Kanjanahaluethai, A., Chen, Z., Jukneliene, D. & Baker, S. C. Membrane topology of murine coronavirus replicase nonstructural protein 3. Virology 361, 391-401 (2007).
60. Oostra, M. et al. Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J. Virol. 82, 12392-12405 (2008).
61. Oostra, M. et al. Localization and membrane topology of coronavirus nonstructural protein 4: Involvement of the early secretory pathway in replication. J. Virol. 81, 12323-12336 (2007).
62. Garbino, J. et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin. Infect Dis. 43, 1009-1015 (2006).
63. Gu, J. et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202, 415-424 (2005).
64. Fouchier, R. A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl Acad. Sci. USA 101, 6212-6216 (2004).
65. van der Hoek, L. et al. Identification of a new human coronavirus. Nature Med. 10, 368-373 (2004).
66. Woo, P. C. et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79, 884-895 (2005).
67. Pyrc, K. et al. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J. Mol. Biol. 364, 964-973 (2006).
68. van der Hoek, L. et al. Croup is associated with the novel coronavirus NL63. PLoS Med. 2, e240 (2005).
69. Donaldson, E. F. et al. Systematic assembly of a full-length infectious clone of human coronavirus NL63. J. Virol. 82, 11948-11957 (2008).
70. Rottier, P. J., Nakamura, K., Schellen, P., Volders, H. & Haijema, B. J. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J. Virol. 79, 14122-14130 (2005).
71. de Groot-Mijnes, J. D., van Dun, J. M., van der Most, R. G. & de Groot, R. J. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J. Virol. 79, 1036-1044 (2005).
72. Vennema, H. et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 64, 1407-1409 (1990).
73. Guan, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276-278 (2003).
74. Riley, S. et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science 300, 1961-1966 (2003).
75. Chinese, S. M. E. C. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303, 1666-1669 (2004).
76. Song, H. D. et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl Acad. Sci. USA 102, 2430-2435 (2005).
77. Li, W. et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24, 1634-1643 (2005).
78. Sheahan, T., Rockx, B., Donaldson, E., Corti, D. & Baric, R. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus. J. Virol. 82, 8721-8732 (2008).
79. Poon, L. L. et al. Identification of a novel coronavirus in bats. J. Virol. 79, 2001-2009 (2005).
80. Lau, S. K. et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl Acad. Sci. USA 102, 14040-14045 (2005).
81. Leung, D. T. et al. Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: False seropositivity due to use of bacterially derived antigens. J. Virol. 80, 8920-8928 (2006).
82. Becker, M. M. et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl Acad. Sci. USA 105, 19944-19949 (2008).
83. Ren, W. et al. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J. Virol. 82, 1899-1907 (2008).
84. Vijgen, L. et al. Complete genomic sequence of human coronavirus OC43: Molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J. Virol. 79, 1595-1604 (2005).
85. Alekseev, K. P. et al. Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences. J. Virol. 82 12422-12431 (2008).
86. Jin, L. et al. Analysis of the genome sequence of an alpaca coronavirus. Virology 365, 198-203 (2007).
87. Lorusso, A. et al. Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J. Virol. 82, 10312-10317 (2008).
88. Woo, P. C. et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J. Virol. 81, 1574-1585 (2007).
89. Dominguez, S. R., O'Shea, T. J., Oko, L. M. & Holmes, K. V. Detection of group 1 coronaviruses in bats in North America. Emerg. Infect. Dis. 13, 1295-1300 (2007).
90. Gloza-Rausch, F. et al. Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg. Infect. Dis. 14, 626-631 (2008).
91. Tong, S. et al. Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg. Infect. Dis. 15, 482-485 (2009).
92. Woo, P. C. et al. Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus. J. Virol. 83, 908-917 (2009).
93. Dong, B. Q. et al. Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China. J. Virol. 81, 6920-6926 (2007).
94. Mihindukulasuriya, K. A., Wu, G., St Leger, J., Nordhausen, R. W. & Wang, D. Identification of a novel coronavirus from a beluga whale by using a panviral microarray. J. Virol. 82, 5084-5088 (2008).
95. Perlman, S. & Dandekar, A. A. Immunopathogenesis of coronavirus infections: Implications for SARS. Nature Rev. Immunol. 5, 917-927 (2005).
96. Bergmann, C. C., Lane, T. E. & Stohlman, S. A. Coronavirus infection of the central nervous system: Host-virus stand-off. Nature Rev. Microbiol. 4, 121-132 (2006).
97. + T-cell-mediated protection from lethal coronavirus encephalomyelitis. J. Virol. 82, 12432-12440 (2008).
98. Kim, T. S. & Perlman, S. Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus. Am. J. Pathol. 166, 801-809 (2005).
99. -/- mice infected with a neurotropic coronavirus. J. Virol. 79, 7113-7120 (2005).
100. + T cells. J. Virol. 64, 4589-4592 (1990).
101. Anghelina, D., Pewe, L. & Perlman, S. Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am. J. Pathol. 169, 209-222 (2006).
102. Deming, D. et al. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med. 3, e525 (2006).
103. Roberts, A. et al. A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 3, e5 (2007).
104. Roberts, A. et al. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J. Virol. 79, 5833-5838 (2005).
105. Versteeg, G. A., Bredenbeek, P. J., van den Worm, S. H. & Spaan, W. J. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 361, 18-26 (2007).
106. Zhou, H. & Perlman, S. Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J. Virol. 81, 568-574 (2007).
107. Spiegel, M. et al. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 79 2079-2086 (2005).
108. He, R. et al. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 311, 870-876 (2003).
109. Kopecky-Bromberg, S. A., Martinez-Sobrido, L., Frieman, M., Baric, R. A. & Palese, P. SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists. J. Virol. 81, 548-557 (2006).
110. Ye, Y., Hauns, K., Langland, J. O., Jacobs, B. L. & Hogue, B. G. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J. Virol. 81, 2554-2563 (2007).
111. Narayanan, K. et al. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 82, 4471-4479 (2008).
112. Wathelet, M. G., Orr, M., Frieman, M. B. & Baric, R. S. Severe acute respiratory syndrome coronavirus evades antiviral signaling: Role of nsp1 and rational design of an attenuated strain. J. Virol. 81 11620-11633 (2007).
113. Zust, R. et al. Coronavirus non-structural protein 1 is a major pathogenicity factor: Implications for the rational design of coronavirus vaccines. PLoS Pathog. 3, e109 (2007).
114. Frieman, M. et al. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 81 9812-9824 (2007).
115. Hussain, S., Perlman, S. & Gallagher, T. M. Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism. J. Virol. 82, 7212-7222 (2008).
116. Zhao, J. et al. Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication. J. Virol. 83, 2368-2373 (2008).
117. Kamitani, W. et al. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl Acad. Sci. USA 103, 12885-12890 (2006).
118. Devaraj, S. G. et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282, 32208-32221 (2007).
119. Cameron, M. J. et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 81, 8692-8706 (2007).
120. Rempel, J. D., Murray, S. J., Meisner, J. & Buchmeier, M. J. Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology 318, 381-392 (2004).
121. Ireland, D. D., Stohlman, S. A., Hinton, D. R., Atkinson, R. & Bergmann, C. C. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 82, 300-310 (2008).
122. Cervantes-Barragan, L. et al. Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon. Blood 109, 1131-1137 (2006).
123. Roth-Cross, J. K., Bender, S. J. & Weiss, S. R. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82, 9829-9838 (2008).
124. Cervantes-Barragan, L. et al. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 182, 1099-1106 (2009).
125. + cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 210, 288-297 (2006).
126. Li, C. K. et al. T cell responses to whole SARS coronavirus in humans. J. Immunol. 181, 5490-5500 (2008).
127. Gu, J. & Korteweg, C. Pathology and pathogenesis of severe acute respiratory syndrome. Am. J. Pathol. 170, 1136-1147 (2007).
128. Chen, J. & Subbarao, K. The immunobiology of SARS. Annu. Rev. Immunol. 25, 443-472 (2007).
129. Subbarao, K. & Roberts, A. Is there an ideal animal model for SARS? Trends Microbiol. 14, 299-303 (2006).
130. McCray, P. B. Jr et al. Lethal infection in K18-hACE2 mice infected with SARS-CoV. J. Virol. 81, 813-821 (2006).
131. Tseng, C. T. et al. SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor. J. Virol. 81, 1162-1173 (2006).
132. Netland, J., Meyerholz, D. K., Moore, S., Cassell, M. & Perlman, S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 82, 7264-7275 (2008).
133. Lee, D. T. et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: A case-control study. Clin. Infect. Dis. 39, 1247-1249 (2004).
134. Xu, J. et al. Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 41, 1089-1096 (2005).
135. Nagata, N. et al. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am. J. Pathol. 172, 1625-1637 (2008).
136. Nagata, N. et al. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J. Virol. 81, 1848-1857 (2007).
137. de Lang, A. et al. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog. 3, e112 (2007).
138. Baas, T. et al. Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. J. Virol. 82, 9465-9476 (2008).
139. Morahan, G., Balmer, L. & Monley, D. Establishment of "The Gene Mine": a resource for rapid identification of complex trait genes. Mamm. Genome 19, 390-393 (2008).
140. Stockman, L. J., Bellamy, R. & Garner, P. SARS: Systematic review of treatment effects. PLoS Med. 3, e343 (2006).
141. Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K. & Baker, S. C. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 76, 3697-3708 (2002).
142. Sims, A. C., Ostermann, J. & Denison, M. R. Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes. J. Virol. 74, 5647-5654 (2000).